ARS Pharma gains FDA clearance to remove age restriction from neffy

What: ARS Pharma has received FDA clearance to remove the age restriction from its prescription medication, neffy.
Why: The clearance is expected to increase the medication's market reach and revenue for the company.
Signal: This development indicates a positive trend for ARS Pharma's growth and expansion in the pharmaceutical industry.
Target: The company is likely to focus on marketing and distribution strategies to capitalize on the expanded market.
Risk: The removal of age restrictions may also increase competition in the market, potentially affecting ARS Pharma's market share.